SELECTIVE NATURAL κ OPIOID AND CANNABINOID RECEPTOR AGONISTS WITH A POTENTIAL ROLE IN THE TREATMENT OF GASTROINTESTINAL DYSFUNCTION

被引:18
|
作者
Fichna, Jakub [1 ]
Schicho, Rudolf [2 ]
Janecko, Anna [1 ]
Zjawiony, Jordan K. [3 ]
Storr, Martin [2 ]
机构
[1] Med Univ Lodz, Fac Med, Dept Biomol Chem, Lodz, Poland
[2] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB T2N 4N1, Canada
[3] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA
关键词
SALVINORIN-A ANALOGS; IRRITABLE-BOWEL-SYNDROME; PLANT-DERIVED HALLUCINOGEN; HERB SALVIA-DIVINORUM; NEOCLERODANE DITERPENES; IN-VITRO; ENDOCANNABINOID SYSTEM; INDUCED HYPERMOTILITY; COLONIC INFLAMMATION; INDUCED INHIBITION;
D O I
10.1358/dnp.2009.22.7.1400219
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A is the major active ingredient of Salvia divinorum, a plant used by the Mazatec Indians of Mexico for spiritual and medical purposes. Different preparations from S. divinorum are also used in traditional heating practices to treat gastrointestinal disorders, including diarrhea. The recent extensive research on salvinorin A and other neoclerodane diterpenoids derived from S. divinorum resulted in a large number of reports describing their isolation, synthesis and structure-activity relationship. This review summarizes the present knowledge on salvinorin A and its analogues, with a focus on the effects on gastrointestinal tissues. We furthermore discuss structural changes in salvinorin A that may facilitate future use of its derivatives in human disease.
引用
收藏
页码:383 / 392
页数:10
相关论文
共 50 条
  • [1] The Role of Efficacy on the Interaction Between Mu Opioid Receptor Agonists and Cannabinoid Receptor Agonists
    Maguire, David R.
    France, Charles P.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S566 - S566
  • [2] Role of efficacy at the mu opioid receptor on the interactions between mu opioid receptor agonists and cannabinoid receptor agonists: antinociception and drug discrimination
    Maguire, David
    France, Charles
    FASEB JOURNAL, 2014, 28 (01):
  • [3] Impact of Efficacy at the μ-Opioid Receptor on Antinociceptive Effects of Combinations of μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists
    Maguire, David R.
    France, Charles P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 351 (02): : 383 - 389
  • [4] Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis
    Porter, Richard Frederick
    Szczesniak, Anna-Maria
    Toguri, James Thomas
    Gebremeskel, Simon
    Johnston, Brent
    Lehmann, Christian
    Fingerle, Juergen
    Rothenhaeusler, Benno
    Perret, Camille
    Rogers-Evans, Mark
    Kimbara, Atsushi
    Nettekoven, Matthias
    Guba, Wolfgang
    Grether, Uwe
    Ullmer, Christoph
    Kelly, Melanie E. M.
    MOLECULES, 2019, 24 (18):
  • [5] Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
    France, Charles P.
    Maguire, David R.
    Minervini, Vanessa
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 151 - 152
  • [6] Opioid Receptor Antagonists for Gastrointestinal Dysfunction
    Hipkin, R. William
    Dolle, Roland E.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 143 - 155
  • [7] Different actions of opioid and cannabinoid receptor agonists in neuropathic pain
    Kohno, Tatsuro
    MOLECULAR PAIN, 2006, 2
  • [8] Antiparkinson potential of δ-opioid receptor agonists
    Hudzik, TJ
    Howell, A
    Payza, K
    Cross, AJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (2-3) : 101 - 107
  • [9] Identification and optimisation of selective cannabinoid receptor 2 agonists
    Gianella-Borradori, Matteo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [10] SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS - RESEARCH TOOLS AND POTENTIAL THERAPEUTIC AGENTS
    ZIMMERMAN, DM
    LEANDER, JD
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) : 895 - 902